Important: This article summarises published research for general informational purposes only. It does not constitute medical or sexual health advice and does not replace the guidance of your doctor, gynecologist, or pharmacist. If you are experiencing changes in sexual function that concern you, consult a healthcare provider.

Of all the effects women report from the contraceptive pill, changes in sex drive tend to generate the most polarized responses. Some people describe a clear and distressing reduction in libido after starting the pill. Others report no change. Some describe the opposite: that removing the anxiety of an unwanted pregnancy made sex feel better than it did before.

All three of these experiences are real, and all three can be explained by what the biology is actually doing. The problem is that most coverage of this topic picks one outcome and runs with it, either reassuring everyone that the pill has no effect, or alarming everyone that it inevitably tanks libido. Neither is accurate.

Here is what the evidence actually shows.


The Mechanism: SHBG and Free Testosterone

To understand the pill-libido relationship, you need to understand one protein: sex hormone-binding globulin, commonly abbreviated as SHBG.

SHBG is produced in the liver and circulates in the bloodstream. Its job is to bind to sex hormones, particularly testosterone, making those hormones inactive. Only testosterone that is not bound to SHBG, called free testosterone, is biologically available to act on tissues. Think of SHBG as a transport vehicle for hormones: hormones on the vehicle cannot do their work; hormones off the vehicle can.

Combined oral contraceptives increase SHBG levels significantly. They do this through two mechanisms working in the same direction. First, the estrogen component stimulates the liver to produce more SHBG. Second, because the pill suppresses ovarian function, the ovaries produce less testosterone than normal. Less testosterone produced, more of that testosterone bound up by elevated SHBG: the result is a substantial reduction in free testosterone levels.

Zimmerman et al., 2014 — Human Reproduction Update

A systematic review and meta-analysis of studies on combined oral contraceptives and testosterone levels in healthy women found that OC use was associated with significant reductions in both total and free testosterone, alongside marked increases in SHBG. The effect was consistent across studies and is considered a well-established pharmacological consequence of combined pill use, not a disputed finding.

That is the biology, and it is not disputed. Where it gets complicated is the next question: does lower free testosterone reliably translate to lower libido in women?


The Disconnect Between Biology and Experience

Here is where the straightforward narrative breaks down. Testosterone is important for female sexual desire, but the relationship between circulating levels and the subjective experience of libido is not linear or predictable in the way that a large percentage reduction might suggest.

Pastor et al., 2013 — European Journal of Contraception and Reproductive Health Care

A systematic review examining the influence of combined oral contraceptives on female sexual desire found that results varied substantially across studies. Reports of decreased libido were present in a significant minority of users but were not the majority experience. Some studies reported no significant change; others reported improvement in certain dimensions of sexual function. The reviewers noted that differences in pill formulation, study design, and outcome measures made direct comparison difficult.

Other research has found that the relief from pregnancy anxiety and from menstrual symptoms, both of which the pill often provides, can increase overall sexual wellbeing in ways that offset or outweigh the biological testosterone effect. This is not a trivial point. Libido in women is not a simple hormonal measurement. It is shaped by context: relationship quality, stress, body image, anxiety, overall health, and yes, hormones. A reduction in free testosterone that would theoretically lower desire can be masked by improvements in other factors.

Conversely, someone who was already experiencing low desire before starting the pill may find that the pill makes a noticeable marginal difference precisely because the contextual factors are not improving things in the other direction. The same biochemical change produces different outcomes in different people because it lands in different contexts.


Progestogen Type: The Variable That Is Too Rarely Discussed

Not all combined pills are the same, and the progestogen component matters considerably for sexual function.

Progestogens vary in their androgenic activity, meaning their resemblance to testosterone and their ability to act on androgen receptors. Older progestogens like levonorgestrel and norethisterone have higher androgenic activity. Newer progestogens like drospirenone and desogestrel have lower androgenic activity or are anti-androgenic. Cyproterone acetate, used in some pills primarily for acne treatment, is strongly anti-androgenic.

This matters because the androgenic activity of the progestogen can partially counteract the testosterone-reducing effect of elevated SHBG, or amplify it, depending on the direction of that activity. In practice, two people on different combined pills can have meaningfully different experiences of libido changes, not because one is more sensitive but because the pills are doing genuinely different things biochemically.

Psychoendocrinology study, 2025 — PMC

Research examining subjective, behavioural, and physiological correlates of stress in hormonal contraceptive users identified distinct cortisol-testosterone relationship patterns across different hormonal contraceptive formulations. This suggests that the internal hormonal environment differs substantially between pill types, and that individual responses to those differences reflect genuine biochemical variation rather than differences in perception alone.

If you have experienced libido changes on one combined pill, switching to a formulation with a different progestogen profile is a legitimate clinical step to discuss with your prescriber. It is not guaranteed to help, but it is not a shot in the dark either.


SHBG After Stopping: The Persistence Question

One of the more concerning and underappreciated findings in this area is what happens to SHBG levels after someone stops using the combined pill.

Panzer et al., 2006 — Journal of Sexual Medicine

In a retrospective study of women with sexual dysfunction, SHBG levels were found to remain significantly elevated compared to women who had never used the pill, even months after discontinuation. The study compared four groups: current OC users, former OC users, women who had never used OCs, and women using non-oral hormonal contraception. Former users showed SHBG levels markedly higher than never-users, suggesting the pill's effect on SHBG does not fully reverse immediately upon stopping for some people.

This finding should not be overstated. The studies in this area are relatively small, the clinical significance varies between individuals, and for many people SHBG levels do normalize over time after stopping. But it is a finding that deserves more attention than it typically receives in standard contraceptive counselling, because someone who stops the pill expecting an immediate libido recovery and does not experience one may blame themselves rather than recognizing that hormonal normalization takes time.

If libido has not improved several months after stopping the pill, this is worth discussing with a healthcare provider rather than assuming the situation is permanent.


The Experience That Goes in the Other Direction

The research on libido and the pill is dominated by coverage of decreases, but increases are also reported and are clinically plausible for specific reasons.

For some people, the pill removes the primary obstacle to desire. Heavy periods, severe dysmenorrhea, and ongoing anxiety about unintended pregnancy all affect sexual interest directly. The mental load of fertility management is real. Removing those factors can improve sexual interest and satisfaction in ways that override or mask any testosterone-mediated effect. This may be particularly relevant for people who start the pill for reasons other than contraception, such as endometriosis or PCOS management, where the underlying condition itself was suppressing wellbeing.

The clinical takeaway is not that the pill improves libido as a rule, but that the effect is genuinely variable. For some people it goes down, for some it stays the same, for some it goes up. The specific pill and the specific person determine which outcome occurs. Research that collapses this variation into an average, and then reports the average as the whole story, loses the part that matters most for any individual decision.


What to Do If You Have Noticed a Change

If you started a pill and noticed a reduction in sexual desire that you want to address, a few things are worth knowing.

  • Timing matters Changes in libido that occur in the first two to three months may represent the body adjusting to a new hormonal environment rather than a permanent new set point. If the change is recent and you are otherwise tolerating the pill well, monitoring for another few weeks before making decisions is reasonable.
  • Formulation is adjustable Moving from a pill with a highly androgenic progestogen to one with a more anti-androgenic or neutral progestogen is a clinical option. Moving from a higher-dose estrogen formulation to a lower-dose one reduces the SHBG-stimulating effect. These are incremental adjustments that sometimes resolve the issue entirely without abandoning hormonal contraception.
  • Progestin-only pills raise SHBG less Progestin-only pills, including desogestrel, do not contain estrogen and therefore do not stimulate SHBG production to the same degree as combined pills. For people who need progestin-only contraception for other reasons, this can be a relevant consideration. For those switching purely because of libido, it is worth discussing the full profile of the progestin-only option with your prescriber first.
  • Stopping is an option, but not the only one Stopping the pill is always available as a choice, but it is worth trying formulation changes before concluding that oral contraceptives are categorically incompatible with your libido. One pill behaving a certain way for you is information about that pill, not about all pills.

Track with Estroclic

Know exactly when you switched, and what changed

If you are trying to understand whether a change in how you feel correlates with starting or switching a pill, having an accurate log of your prescription history and timing is useful data to bring to a doctor's appointment. Estroclic tracks your pill precisely so that timeline is already there when you need it.

Download on Android

Frequently asked questions

Does the birth control pill lower sex drive?

It can, for some people. Combined pills raise SHBG, which binds testosterone and reduces the amount of free testosterone available in the body. Systematic reviews confirm a significant reduction in free testosterone among combined pill users. However, many people report no change in libido, and some report improvement, particularly if the pill relieves anxiety about pregnancy or reduces symptoms like heavy or painful periods.

Which birth control pill is least likely to affect libido?

Pills with lower androgenic progestogens, such as drospirenone or desogestrel, may have less impact on libido than older formulations containing levonorgestrel or norethisterone. Lower-dose estrogen formulations raise SHBG less than higher-dose ones. This is worth discussing with your prescriber if libido is a concern, either before you start or after you have noticed a change.

Can the pill permanently affect libido?

Research has found that SHBG levels remain elevated in some women for months after stopping the pill, which may contribute to persistent effects for a subset of people. For most, hormonal levels normalize over time after discontinuation. If libido does not improve several months after stopping, this is worth raising with a healthcare provider, as other contributing factors may need to be assessed.

Does the mini-pill affect libido?

Progestin-only pills, including desogestrel, do not contain estrogen and therefore do not stimulate SHBG production to the same degree as combined pills. The evidence for libido effects of progestin-only pills is less established, and individual responses vary. They are generally considered to have a smaller impact on free testosterone than combined pills.

How long after stopping the pill will libido return to normal?

There is no universal timeline. Ovarian function typically resumes within one to three months after stopping combined pills. SHBG may take longer to normalize for some individuals. If libido does not improve over several months after stopping, this is worth raising with a healthcare provider, as other factors may be contributing.

Is reduced libido on the pill worth raising with a doctor?

Yes. Reduced libido is a legitimate clinical side effect, not a trivial complaint. Your prescriber can review your formulation, suggest alternatives with different progestogen profiles or lower estrogen doses, and help you weigh the options. You do not need to manage it alone or accept it as inevitable.

This article is for general informational purposes only and does not constitute medical, pharmaceutical, or clinical advice. The information presented summarises published research and guidance at the time of writing and may not reflect the most current guidance in your country or for your individual circumstances. Always consult your doctor, gynecologist, pharmacist, or other qualified healthcare professional before making any decisions about your contraception or health. Estroclic is a personal tracking app, not a medical device or clinical service.
Sources
  • Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, Blankenstein MA, Fauser BC. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(1):76-105. Systematic review confirming significant reductions in total and free testosterone alongside SHBG elevation in combined OC users. pubmed.ncbi.nlm.nih.gov
  • Panzer C, Wise S, Fantini G, Kang D, Munarriz R, Guay A, Goldstein I. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. J Sex Med. 2006;3(1):104-113. Found SHBG levels remained significantly elevated in former OC users compared to never-users, even months after discontinuation. pubmed.ncbi.nlm.nih.gov
  • Pastor Z, Holla K, Chmel R. The influence of combined oral contraceptives on female sexual desire: a systematic review. Eur J Contracept Reprod Health Care. 2013;18(1):27-43. Systematic review finding variable libido outcomes across studies; decreased desire reported in a minority; formulation differences highlighted as a key variable. pubmed.ncbi.nlm.nih.gov
  • Davis SR, Wahlin-Jacobsen S. Testosterone in women -- the clinical significance. Lancet Diabetes Endocrinol. 2015;3(12):980-992. Authoritative review of testosterone's role in female sexual function and the non-linear relationship between circulating levels and subjective desire. pubmed.ncbi.nlm.nih.gov
  • Sitruk-Ware R, Nath A. Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Pract Res Clin Endocrinol Metab. 2013;27(1):13-24. Overview of androgenic and anti-androgenic progestogen profiles and their differential biological effects. pubmed.ncbi.nlm.nih.gov
  • Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: a review. J Sex Med. 2012;9(9):2213-2223. Review of evidence on hormonal contraceptive effects on sexual function, including desire, arousal, and orgasm across different methods. pubmed.ncbi.nlm.nih.gov
  • Subjective, behavioural and physiological correlates of stress in women using hormonal contraceptives. PMC. 2025. Found distinct cortisol-testosterone relationship patterns across different hormonal contraceptive formulations, supporting real biochemical variation between pill types. pmc.ncbi.nlm.nih.gov